Caribou Biosciences
NasdaqGS:CRBU
$ 1,86
$-0,09 (-4,62%)
1,86 $
$-0,09 (-4,62%)
End-of-day quote: 04/07/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$0,00
Earnings Per Share
$0,12
Revenue Per Share
0,00%
Gross Margin %
$0,19 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$0,00
Revenue Per Share
$0,12
Gross Margin %
0,00%
Market Cap
$0,19 B
Long-Term Debt
$0,00 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020
EPS Earnings Per Share $-1,59 $-1,65 $-1,38 $-1,64 $-2,11 $-7,30
Earnings Earnings $-153,66M $-153,45M $-124,63M $-0,00M $-0,00M $-0,00M
RPS Revenue Per Share $0,00 $0,12 $0,11 $0,38 N/A N/A N/A
Revenue Revenue $0,00M $11,16M $9,99M $34,48M $0,00M $0,00M $0,00M
OCF Operating Cash Flow $0,00M $-134,71M $-138,20M $-93,29M $0,00M $0,00M $0,00M
FCF Free Cash Flow $0,00M $-138,79M $-143,08M $0,00M $0,00M $0,00M $0,00M
OM Operating Margin 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% -292,24%
GM % Gross Margin % 0,00% 0,00% 100,00% -225,07% 0,00% 0,00% -178,50%
FCFS Free Cash Flow Per Share $0,00 $-1,20 $-1,60 $-1,42 $-1,61 $-1,13 $-4,04
LT Debt Long-Term Debt N/A N/A N/A N/A N/A N/A $0,92M
Sha. Stocks 96,64M 96,64M 93M 90,31M 61M 60,19M 0M
×